Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection
about
Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000-12Update on medical and regulatory issues pertaining to compounded and FDA-approved drugs, including hormone therapy.Raman Spectroscopy: A Sensitive and Specific Technique for Determining the Accuracy of Compounded Pharmaceutical FormulationsPotential risks of pharmacy compounding.Pharmacy compounding primer for physicians: prescriber beware.Quality assessment of compounded 17-hydroxyprogesterone caproate17 α-hydroxyprogesterone caproate (Makena®): a guide to its use in the prevention of preterm birth.
P2860
Q26864307-9265F7C8-999B-47F4-8C0C-A820C6380EB4Q28081931-2CAB7BF2-5B28-4E00-8ACA-5EF7EF1E5465Q28821666-D9D90B05-4521-4C2E-BCFA-A289B564A981Q36767791-D40B25B8-968C-4D2B-8A7F-137373D5B7DDQ36963951-8A8E198A-8269-41E9-B4A5-848463D5B8F6Q37612302-9F47AF9B-1AEF-46AB-8CAA-37DA5657BF48Q46882196-7C4CA5F6-4F05-40F1-AE75-438A2C823C99
P2860
Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Quality investigation of hydro ...... tical ingredient and injection
@ast
Quality investigation of hydro ...... tical ingredient and injection
@en
type
label
Quality investigation of hydro ...... tical ingredient and injection
@ast
Quality investigation of hydro ...... tical ingredient and injection
@en
prefLabel
Quality investigation of hydro ...... tical ingredient and injection
@ast
Quality investigation of hydro ...... tical ingredient and injection
@en
P2860
P1476
Quality investigation of hydro ...... tical ingredient and injection
@en
P2093
John L Chollet
Michael J Jozwiakowski
P2860
P304
P356
10.3109/03639045.2012.662511
P407
P577
2012-02-13T00:00:00Z